Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1153)
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$5.61
Total Value
$56.05K
Shares Held After
3,027,000
% of Holdings
0.3%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
63,945
Price
$3.40
Total Value
$217.41K
Shares Held After
533,122
% of Holdings
10.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
37,263
Price
$15.19
Total Value
$566.02K
Shares Held After
2,180,518
% of Holdings
1.7%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
100
Price
$15.48
Total Value
$1.55K
Shares Held After
434,188
% of Holdings
0.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,841
Price
$14.83
Total Value
$457.37K
Shares Held After
434,288
% of Holdings
6.6%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
1,108
Price
$33.38
Total Value
$36.99K
Shares Held After
133,986
% of Holdings
0.8%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
300
Price
$32.25
Total Value
$9.67K
Shares Held After
133,986
% of Holdings
0.2%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
4,423
Price
$31.38
Total Value
$138.81K
Shares Held After
133,986
% of Holdings
3.2%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
205
Price
$29.71
Total Value
$6.09K
Shares Held After
133,986
% of Holdings
0.2%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
2,115
Price
$28.94
Total Value
$61.21K
Shares Held After
133,986
% of Holdings
1.6%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
1,108
Price
$33.38
Total Value
$36.99K
Shares Held After
133,986
% of Holdings
0.8%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$13.01
Total Value
$230.50K
Shares Held After
213,867
% of Holdings
7.7%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
2,400
Price
$6.38
Total Value
$15.31K
Shares Held After
32,523
% of Holdings
6.9%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
29,319
Price
$6.53
Total Value
$191.45K
Shares Held After
34,923
% of Holdings
45.6%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
2,500
Price
$2.30
Total Value
$5.75K
Shares Held After
29,375
% of Holdings
7.8%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
94,087
Price
$3.43
Total Value
$322.72K
Shares Held After
597,067
% of Holdings
13.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.56
Total Value
$258.45K
Shares Held After
438,526
% of Holdings
4.2%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$40.97
Total Value
$819.40K
Shares Held After
2,231
% of Holdings
90.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.10
Total Value
$93.00K
Shares Held After
6,229,863
% of Holdings
0.5%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.10
Total Value
$124.00K
Shares Held After
906,556
% of Holdings
4.2%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
1,000
Price
$64.75
Total Value
$64.75K
Shares Held After
153,902
% of Holdings
0.6%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$65.21
Total Value
$228.23K
Shares Held After
153,902
% of Holdings
2.2%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
3,000
Price
$60.00
Total Value
$180.00K
Shares Held After
28,975
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
124
Price
$569.62
Total Value
$70.63K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
296
Price
$568.74
Total Value
$168.35K
Shares Held After
40,637
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
322
Price
$567.64
Total Value
$182.78K
Shares Held After
40,933
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
431
Price
$566.63
Total Value
$244.22K
Shares Held After
41,255
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,737
Price
$565.66
Total Value
$982.54K
Shares Held After
41,686
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,512
Price
$564.67
Total Value
$1.42M
Shares Held After
43,423
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,449
Price
$563.47
Total Value
$816.46K
Shares Held After
45,935
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,069
Price
$562.35
Total Value
$601.16K
Shares Held After
47,384
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$561.67
Total Value
$202.20K
Shares Held After
48,453
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$560.36
Total Value
$291.38K
Shares Held After
48,813
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$559.21
Total Value
$204.11K
Shares Held After
49,333
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
276
Price
$558.32
Total Value
$154.10K
Shares Held After
49,698
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
39
Price
$556.89
Total Value
$21.72K
Shares Held After
49,974
% of Holdings
0.1%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF DEV. OFFICER
Shares
27,661
Price
$9.36
Total Value
$258.91K
Shares Held After
668,505
% of Holdings
4.0%
OmniAb, Inc. (OABI)
GUSTAFSON KURT A — Executive VP, Finance and CFO
Shares
6,913
Price
$1.49
Total Value
$10.30K
Shares Held After
261,483
% of Holdings
2.6%
OmniAb, Inc. (OABI)
Berkman Charles S — Chief Legal Officer
Shares
7,157
Price
$1.49
Total Value
$10.66K
Shares Held After
399,085
% of Holdings
1.8%
OmniAb, Inc. (OABI)
FOEHR MATTHEW W — Director
Shares
19,244
Price
$1.49
Total Value
$28.67K
Shares Held After
4,420,492
% of Holdings
0.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
1,030
Price
$22.20
Total Value
$22.87K
Shares Held After
27,865
% of Holdings
3.6%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
2,709
Price
$22.20
Total Value
$60.14K
Shares Held After
62,836
% of Holdings
4.1%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
40,000
Price
$2.03
Total Value
$81.20K
Shares Held After
203,797
% of Holdings
19.6%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
45
Price
$31.96
Total Value
$1.44K
Shares Held After
141,029
% of Holdings
0.0%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
1,214
Price
$31.02
Total Value
$37.66K
Shares Held After
141,029
% of Holdings
0.9%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
1,104
Price
$31.02
Total Value
$34.25K
Shares Held After
141,029
% of Holdings
0.8%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
102,395
Price
$3.51
Total Value
$359.41K
Shares Held After
691,154
% of Holdings
12.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
83,332
Price
$14.41
Total Value
$1.20M
Shares Held After
2,217,781
% of Holdings
3.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.33
Total Value
$273.13K
Shares Held After
442,864
% of Holdings
4.1%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
2,653
Price
$20.45
Total Value
$54.25K
Shares Held After
1,122,626
% of Holdings
0.2%
Showing 1–50 of 1153 transactions (page 1 of 24)